Moreover, we found that overexpression of the p53 mutant alleviated the effects of UBA2 knockdown on cell proliferation and apoptosis, further indicating that UBA2 may play its role via the p53 mutant in the ccRCC cell line 786-O. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.